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Abstract
Background. There is limited research on the interaction of both positive and negative daily-life
environments with stress-related genetic variants on psychotic experiences (PEs) and negative
affect (NA) across the extended psychosis phenotype. This study examined whether the FK506
binding protein 51 (FKBP5) variability moderates the association of positive and negative
experiences in the moment with PEs and NA in participants with incipient psychosis and their
nonclinical counterparts.
Methods.A total of 233 nonclinical and 86 incipient psychosis participants were prompted for a
1-week period to assess their day-to-day experiences. Participants were genotyped for four
FKBP5 single nucleotide polymorphisms (rs3800373, rs9296158, rs1360780, and rs9470080).
Results. Multilevel analyses indicated that, unlike the risk haplotype, the protective FKBP5
haplotype moderated all the associations of positive experiences with diminished PEs and NA in
incipient psychosis compared with nonclinical group.
Conclusions. Participants with incipient psychosis showed symptomatic improvement when
reporting positive appraisals in the interpersonal domain, which suggests that these act as a
powerful coping mechanism. The fact that this occurred in daily-life underscores the clinical
significance of this finding and pinpoints the importance of identifying protective mechanisms.
In addition, results seem to concur with the vantage sensitivity model of gene–environment
interaction, which poses that certain genetic variants may enhance the likelihood of benefiting
from positive exposures.
Introduction
Extensive evidence indicates that the psychosis phenotype is expressed across a dynamic
continuum that ranges from nonclinical to clinical manifestations [1, 2]. Individuals with
nonclinical, subclinical, and early-stage manifestations offer important assets for the study of
both risk and protective mechanisms, as they are less affected by the wide array of confounding
effects associated with overt psychopathology and chronicity. Thus, investigating continuities as
well as discontinuities between clinical and nonclinical expressions may help to elucidate the
heterogeneity that characterizes pathways to psychosis and the identification of protective factors
[3]. In this regard, the study of patterns of gene–environment interactions (GE) in clinical and
nonclinical populations may contribute to our understanding of common and differential
mechanisms operating across the psychosis continuum [4].
Recent GE studies indicate that the interaction of genetic variants on the FK506 binding
protein 5 (FKBP5) gene with psychosocial stressors is associatedwith psychotic experiences (PEs)
in clinical and nonclinical samples [5-8]. Compelling evidence has suggested that individual
variation in the FKBP5 gene is linked to the dysregulation of the hypothalamus–pituitary–adrenal
(HPA) axis, which has been identified as a critical neurobiological mechanism underlying the
emergence of psychotic symptoms [9]. In particular, the minor risk alleles (C, A, T, T) of at least
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rs9470080, respectively), as compared with the nonrisk or protec-
tive alleles (A, G, C, C), have been associated with a decreased
sensitivity of the glucocorticoid receptor to circulating cortisol,
entailing a diminished negative feedback regulation of the HPA
axis that results in an abnormal prolongation of the stress response
[10]. Importantly, the rs1360780 SNPs included in a functional
haplotype confers differential effects in FKBP5mRNA and protein
levels mediated by a differential chromatin conformation, resulting
in different transcriptional effects between risk and protective
alleles [11]. So far, research has predominantly focused on analyz-
ing the effects of the interplay of FKBP5 variation with adverse
environmental exposures on psychotic phenomena guided by
diathesis-stress model for schizophrenia [12], greatly understudy-
ing the interaction of genetic variation with positive, and thus
putative protective, environmental factors. However, individuals
may differ in their susceptibility to the environment across a range
of exposures (not just negative ones) and, therefore, moderation
effects by genetic variation should also be expected in relation to the
benefit that individuals may obtain from positive experiences
[13]. In light of this, new frameworks under which to consider
GE interactions have been developed. For example, the differen-
tial susceptibility model [14] highlights that individuals traditionally
considered to carry greater vulnerability may be better conceptu-
alized as being more plastic, sensitive, or malleable to the environ-
ment (“for worse and for better”). That is, it suggests that the same
genetic variants involved in increasing the negative effects of
adverse experiences could also be involved in enhancing the like-
lihood of benefiting from positive ones. Another relevant model of
GE interactions is vantage sensitivity [15], which poses that
certain genetic variants may enhance the likelihood of benefiting
from positive exposures (without also implying an increase in the
susceptibility to negative exposures)—that is, vantage sensitivity is
more than the “bright side” of environmental sensitivity as covered
in differential susceptibility models. Although these approaches
have been scarcely considered within the psychosis field, the per-
tinence of incorporating the assessment of positive environmental
experiences and examining potential beneficial effects is under-
scored by GE investigations in other stress-related phenotypes.
For instance, in depression research, it has been shown that the
impact of BDNF Val66Met genotype on stress sensitivity may be
dependent on the experience of daily-life positive emotions [16].
Another relevant issue that has received increasing attention in
the context of GE research has been the importance of refining
environmental measures [17]. In this regard, the enhancement of
precision, reliability, and ecological validity offered by the use of
ambulatory assessment strategies (such as experience sampling
methodology [ESM] or ecological momentary assessment) should
be helpful for examining genetic moderation of the effects of both
positive and negative microlevel experiences (i.e., those occurring in
themoment in real-life contexts; [18]). To the best of our knowledge,
there are no ambulatory assessment studies investigating the poten-
tial moderation of individual genetic variation involved in the reg-
ulation of the stress system, such as FKBP5 variants, in the
association of positive and negative momentary experiences on the
psychosis phenotype. Importantly, there is also a lack of studies with
ecological validity that examine plausible genetic-environmental
interplay differences between nonclinical and clinical individuals,
which should allow to identify risk and resilience mechanisms and
targets for prophylactic interventions [19].
Therefore, the present study used ESM to elucidate the extent to
which the interplay of FKBP5 variability with both positive and
negative exposures impacts the expression of PEs, as well as
negative affect (NA), in daily-life across nonclinical and clinical
levels of expression of the extended psychosis phenotype. Specifi-
cally, we examined whether the interaction effects of positive and
negative experiences with the FKBP5 haplotype on PEs and NA
differed between subjects with and without need for care, that is, in
incipient psychosis and nonclinical groups. We predicted that the
association of both positive and negative momentary experiences
with symptoms and NA would be greater in an incipient psychosis
group than in a nonclinical group, and that these associations
would be moderated by FKBP5 variability.
Materials and Methods
Participants
Data were collected as part of an ongoing longitudinal investigation
examining psychosis risk and resilience [20]. The present study
included a total of 319 participants reflecting different levels of
expression of the psychosis phenotype for which ESM and genetic
data were available. The nonclinical group was comprised of
233 students recruited from university and technical schools who
scored across a range on questionnaire assessments of schizotypy
and psychosis-proneness questionnaires (mean age = 20.0 years,
SD= 2.9 years; 25.3% males). We invited participants from our
screening samples who had standard scores based upon sample
norms of at least 1.0 on the positive or negative schizotypy dimen-
sions of the Wisconsin Schizotypy Scales [21], the suspiciousness
scale of the Schizotypal Personality Questionnaire [22], or the
positive symptom subscale of the Community Assessment of Psy-
chic Experiences [23], and randomly selected participants who had
standard scores below 1.0 on each of these. The goal of this
enrichment procedure was to ensure adequate variability of schi-
zotypy traits and avoid having a “super healthy” control sample.
The final nonclinical sample contained 198 university and 35 tech-
nical school students.
The incipient psychosis group included 86 patients recruited at
the Sant Pere Claver Health Foundation (mean age = 22.3 years,
SD= 4.7 years; 69.8%males). Specifically, the sample for this study
consisted of 55 diagnosed with at-risk mental states for psychosis
(ARMS) and 31 first episode psychosis (FEP) patients (6 of them
met criteria for affective psychoses including 4 with bipolar I
disorder and 2 with unipolar depression with psychosis). Patients’
inclusion criteria were age between 14 and 40 years and IQ≥ 75.
ARMS-criteria were established by the Comprehensive Assess-
ment of At-Risk Mental States [24] and/or the Schizophrenia
Proneness Instrument-Adult version [25]. FEP-patients met
DSM-IV-TR criteria for any psychotic disorder or affective disor-
der with psychotic symptoms as established by the Structured
Clinical Interview for DSM-IV [26]. Ethical approval was obtained
from the University Ethics committee and participants provided
written informed consent.
Measures
Participants received personal digital assistants that signaled them
randomly eight times daily for 1 week to complete brief assessments
of affect, cognition, activities, and PEs on 7-point scales ranging
from 1 (not at all) to 7 (very much). A detailed description of the
ESM assessment and validation data can be found in previous
studies [20]. The positive and negative experience items used in
the present study focused on two main domains of daily-life:
situational and interpersonal. We focused on two content areas
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that have been shown as highly relevant in psychosis and tested out
in ESM research: situational stress and appraisals of social rejection
[20]. Thus, the negatively valenced items were: “My current situa-
tion is stressful” and (when alone) “I am alone because people do
not want to be with me.” The positively valenced items were: “My
current situation is positive” and “Right now I feel that others care
about me.” Two ESM indices were created and used as outcome
measures: (i) PEs was computed by averaging the scores for
10 items: unusual senses, unusual thoughts, feeling weird, losing
control, difficulty controlling thoughts, familiar things seeming
strange, feeling suspicious, feeling mistreated, hearing/seeing
things others could not, and passivity (coefficient α= 0.95);
(ii) NA was the mean of four items: feeling anxious, sad, angry,
and guilty (coefficient α=0.89).
Genetic data
Genomic DNA was extracted from saliva in the nonclinical sample
and blood in the incipient psychosis samples. Four single-
nucleotide polymorphisms (SNPs) included in a previously
described functional FKBP5 haplotype [27] were genotyped using
TaqMan 50 exonuclease assay (Applied Biosystems): rs3800373,
rs9296158, rs1360780, and rs9470080. Compliance with Hardy–
Weinberg equilibrium was verified for all polymorphisms in both
samples (all p> 0.05). Haplotypes were estimated using PHASE,
after confirming that the four SNPs were in high linkage-
disequilibrium (D0 > 0.9; r2 > 0.7). Participants were classified into
three groups for analyses based on previous studies [19,28]:
(i) carriers of at least one protective haplotype and no risk haplo-
types (AGCC/, n=157), (ii) carriers of one risk haplotype and
one protective haplotype (AGCC/CATT, n=118), and
(iii) carriers of at least one risk haplotype and no protective hap-
lotypes (CATT/, n=44). Haplotypic frequencies are presented in
Table S1).
Statistical analyses
ESM data have a hierarchical structure in which ESM ratings (level
1 data) are nested within participants (level 2 data). Linear mixed
models were used to control for within-subject clustering ofmultiple
observations using the “xtmixed” command in Stata 12 [29]. Graphs
were generated with the R program (www.r-project.org).
Two types of multilevel analyses were conducted in the present
study. First, in order to examine whether the effect of the FKBP5
haplotype on PEs and NA differed between nonclinical and incipient
psychosis groups, we assessed the main effects of level 2 predictors on
level 1 outcomevariables (PEs andNA).The level 2 predictorswere the
FKBP5 haplotype (0=AGCC/; 1=AGCC/CATT; 2=CATT/),
the group status (incipient psychosis vs nonclinical groups), and the
interaction term (FKBP5 haplotype group status).
Second, to examine whether the potential moderating role of the
FKBP5 haplotype in the association of momentary appraisals with
daily-life outcomes differed between nonclinical and incipient psy-
chosis groups, cross-level interactions were conducted. Cross-level
interactions tested whether level 1 slopes (i.e., the association of
positive and negative experiences with symptoms and NA) varied
as a function of level 2 variables FKBP5 haplotype, group status, and
FKBP5haplotype group status). Finally, when a level 2 interaction
was significant, the effect of the interaction was examined in each
FKBP5 haplotype group using simple slopes analyses. Please note
that multiple comparisons in multilevel modeling do not present
the risk of alpha inflation that is seen in traditional unilevel ana-
lyses, so following Gelman et al. [30] multiple testing corrections
were not conducted.
Results
Main effects of level 2 predictors (FKBP5 and group)
Results indicated that the FKBP5 haplotype was not associated with
momentary PEs or NA (Table 1). However, as expected, partici-
pants in the incipient psychosis group experienced more PEs and
NA than individuals in the nonclinical group (p < 0.001). No
interaction effects were found between the FKBP5 haplotype and
group on PEs or NA in daily-life. Thus, haplotype risk and protec-
tive groups were unassociated with the overall reports of symptoms
and affect in daily life.
Cross-level interactions
Cross-level interaction analyses examined whether the FKBP5 hap-
lotype, group status, and their interaction moderated the associa-
tions of positive and negative experiences with PEs andNA in daily-
life (Table 2). All negative appraisals in the moment (situational
stress and feeling unwanted by others) were associated with
increased PEs and NA in the moment, whereas all positive experi-
ences (current situation being positive and feeling cared for by
others) were associated with decreased PEs and NA.
Regardingmoderation effects, the FKBP5 haplotype did not mod-
erate the associations of positive or negative appraisals with PEs or
Table 1. Main effects of the FKBP5 haplotype, group status, and their interaction on psychotic experiences and negative affect (n = 319).
Level 1 criterion
Level 2 predictors
FKBP5 haplotype Group: early-psychosis vs nonclinical FKBP5 haplotypegroup
γ01 (df = 316) γ02 (df = 316) γ03 (df = 315)
ESM psychosis
Psychotic experiences index 0.026 (SE = 0.036) 0.447 (SE = 0.058)*** 0.138 (SE = 0.082)
ESM affect
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NA.Group statusmoderated the associations of situational stresswith
PEs and NA (Table 2). Analysis of simple slopes showed that the
associations were greater in the incipient psychosis group (PEs: 0.126,
SE= 0.013, p<0.001;NA: 0.285, SE= 0.023, p<0.001) comparedwith
the nonclinical group (PEs: 0.046, SE= 0.04, p<0.001; NA: 0.218, SE
= 0.011, p<0.001). The group status also moderated the associations
of the two positive appraisals with PEs, but not NA, in the moment.
That is, as positive experiences increased, incipient psychosis
participants experienced greater decreases in symptoms (positive
situation: 0.114, SE= 0.014, p<0.001; others care about me:
0.078, SE= 0.017, p<0.001) than their nonclinical counterparts
(positive situation: 0.055, SE= 0.005, p<0.001; others care about
me: 0.032, SE= 0.004, p<0.001).
The FKBP5 haplotype by group interaction moderated all the
associations of positive, but not negative, experiences with decreased
PEs andNA in daily-life (Table 2). As shown in Figure 1, simple slope
analyses indicated that, among protective haplotype carriers
(i.e., AGCC/), the positive appraisal of the situation was associated
with decreased PEs in the incipient psychosis group compared with
the nonclinical group (PEs:0.087,SE=0.018,p<0.001;NA:0.043,
SE=0.038, ns). In addition, among protective haplotype carriers, the
positive experience of feeling cared for by others was associated
with decreased PEs, as well as NA, in the incipient psychosis
group compared with the nonclinical group (PEs: 0.096, SE=
0.017, p<0.001; NA: 0.066, SE=0.033, p<0.050; see Figure 2).
Furthermore, among the mixed haplotype (i.e., one protective and
one risk haplotype carriers; AGCC/CATT), the experience of a pos-
itive situation was associated with diminished PEs in incipient psy-
chosis in comparison to nonclinical group (situation positive—PEs:
0.040, SE=0.020, p<0.050; NA: 0.002, SE=0.040, ns; others care
about me—PEs: 0.004, SE=0.022, ns; NA: 0.014, SE=0.036, ns).
Finally, among risk haplotype carriers (i.e., CATT/), no group
differences were found in the association of both positive appraisals
with symptoms (situation positive—PEs:0.017, SE=0.035, ns; NA:
0.135, SE=0.079, ns; others care about me—PEs:0.035, SE=0.027,
ns; NA: 0.088, SE=0.055, ns).
Discussion
Main findings
The present work investigated whether the interplay between
FKBP5 variation and contextual factors is not limited to adverse
experiences, but expands into the full spectrum of positive and
negative experiences in real-life contexts. The study raised a novel
finding indicating that the interaction of FKBP5 variation with
positive experiences is associated with diminished PEs and NA,
in incipient psychosis compared with nonclinical group. Another
relevant finding from the current study was that individuals with
incipient psychosis, in comparison to their nonclinical counter-
parts, reported greater psychotic reactivity to negative, but also to
positive, experiences in daily-life. Notably, the incipient psychosis
group differed from the nonclinical group in terms of symptomatic
reactivity to positive, but not negative, appraisals in the interper-
sonal domain, suggesting that positive interpersonal appraisals may
act as a relevant coping mechanism for help-seeking individuals,
ameliorating the intensity of symptom expression in the realm of
daily-life.
The interpretation of these findings appears relevant at both
basic and applied levels. At a basic science level, they seem to concur
with numerous studies showing that environmental enrichment
induces dramatic changes on brain and behavior in animal models
Table 2. Moderation by FKBP5 haplotype, group, and the FKBP5 group interaction of the association between both positive and negative appraisals with
psychotic experiences and negative affect (n = 319).
Level 1 criterion








γ10 (df = 316) γ11 (df = 316) γ12 (df = 316) γ13 (df = 315)
Appraisals Coeff. (SE) Coeff. (SE) Coeff. (SE)
ESM psychosis Negative appraisals
Psychotic experiences index Situation stressful 0.042 (0.007)*** 0.007 (0.007) 0.080 (0.011)*** 0.013 (0.015)
Alone b/c not wanted 0.104 (0.032)** 0.016 (0.029) 0.041 (0.040) 0.005 (0.059)
Positive appraisals
Situation positive 0.059 (0.008)*** 0.005 (0.008) 0.059 (0.013)*** 0.035 (0.018)*
Others care about me 0.034 (0.008)*** 0.002 (0.008) 0.045 (0.013)*** 0.040 (0.018)*
ESM affect Negative appraisals
Negative affect index Situation stressful 0.216 (0.015)*** 0.004 (0.014) 0.065 (0.023)** 0.013 (0.033)
Alone b/c not wanted 0.156 (0.050)** 0.086 (0.046) 0.001 (0.060) 0.025 (0.092)
Positive appraisals
Situation positive 0.277 (0.018)*** 0.021 (0.017) 0.001 (0.026) 0.075 (0.037)*




aThe table reports the coefficient of the association of the level 1 predictor and criterion for the analyses of FKBP5 and group variables entered simultaneously.
bThe effect of FKBP5group interaction term was examined over and above the main effects.
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[31]. It has been shown that environmental enrichment improves
behavioral impairment in animal models of schizophrenia. Impor-
tantly, environmental enrichment diminishes the long-term nega-
tive effects of stress on altered HPA function [32]. A specific effect
of environmental enrichment on this reversal role of HPA dysre-
gulation is seen in animal models of transgenerational and multi-
generational prenatal stress [33]. In addition, it has been shown that
the exposure to environmental enrichment remarkably reduced the
stress-sensitive phenotype induced by ancestral stress and also
improved several levels of HPA axis function.
From a clinical stance, the present findings support increasing
evidence indicating that environmental factors in general [34], and
daily-life experiences in particular [35], are potent factors in terms
of influencing psychotic reactivity and expression. Research has
been predominantly guided by diathesis-stress model, and there is a
growing criticism regarding the disproportionate focus on stressors
and negative life events and the negligence of positive environ-
ments. New conceptual frameworks, such as the diathesis-stress-
support model [36], suggest that social support can boost skills and
competences, prevent risk accumulation, and are essential for an
individual’s progress toward recovery. In this sense, the recent
growing impact of Positive Psychology [37,38] and Positive Psy-
chiatry [39] has demonstrated that persons with psychosis can
experience positive psychological features [40]. Regarding ESM
research, one study revealed that individuals with persistent PEs
showed more social reward sensitivity than individuals without
persistent PEs [41]. This realization has recently encouraged inter-
est in developing momentary clinical interventions with
ecologically valid tools [42], providing new opportunities for treat-
ment. The development of recent positive psychological interven-
tions [43] and the new upsurge of real world interventions in
mental health [44] may be particularly important in psychosis field.
Clinical relevance of individual genetic differences in the
response to positive experiences
Although to the best of our knowledge there are no previous studies
investigating whether the FKBP5 haplotype moderates the associ-
ation of positive experiences with symptom expression in daily-life,
findings seem to resonate with recent work in the context of
responsiveness to psychotherapy in Posttraumatic stress disorder
(PTSD) [45]. The study examined whether improvement in PTSD
symptoms after exposure-based therapy differed as a function of
FKBP5 (rs1360780) variability. They found that, although no
genetic differences on symptoms emerged between baseline and a
4-month follow-up, individuals homozygous for the protective
rs1360780 C-allele continued to show a reduction in symptoms
in the 10-month follow-up, whereas this was not found for carriers
of the risk T-allele [45]. According to Pluess [15], these results
suggest that the C-allele may enhance vantage sensitivity in the
context of exposure-based therapy in this population. Given that in
the present study, the protective haplotype was associated with
diminished symptoms in the context of positive experiences for
incipient psychosis participants (but not increased symptoms in the
context of negative ones), our findings would seem to be in line with
a vantage sensitivity interpretation for incipient psychosis as
Figure 1. Groupdifferences betweennonclinical andearly psychosis groups in the interactionof situationpositivewith FKBP5 haplotypeonpsychotic experiences andnegative affect.
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compared with nonclinical group. It must be noted, although, that
we did not employ specific statistical tests [46] to formally inves-
tigate such pattern of GE interactions.
Recent etiological evidence that advocates for positive and
negative effects of genetic and environment factors on the devel-
opmental trajectories of psychosis has not yet been embodied into
preventive interventions. In this regard, it is imperative to devise
new real-world targeted strategies based on knowledge about the
individual capacity of people at-risk or with psychotic symptoms in
showing differential reactivity to negative and positive factors. This
is a critical issue, asmany clinicians, even those with knowledge and
sensitivity toward psychological factors in incipient psychosis
services with a preventive framework, continue to treat persons
with any degree of psychosis expression in a very different manner
to that employedwith persons presentingwith risk for or overt non-
psychotic disorders. Most likely, decades of a narrow conceptual-
ization of psychosis as the straightforward product of a genetically
determined brain disease, the historically engraved “broken brain”
view of schizophrenia [47] and the youth of a developing agreed
upon conceptual framework in which to integrate the dynamic,
malleable, and reactive nature of psychosis experiences, partly
account for this situation.
Strengths and limitations
The present study has a number of strengths, including the estima-
tion of a haplotype that increases the power to detect genetic
associations [48] and the use of valid ecological measures that are
considered to increase the power and reliability of GE research
[49]. In this sense, the design of the study offers a useful model for
researchers wanting to examine complex GE effects in the real
world. As regards to limitations, these include gender differences in
the composition of nonclinical and clinical samples, which may
limit the generalizability of findings; and the fact that causal infer-
ences of the effects of momentary positive and negative experiences
cannot be definitively drawn given that ESMpredictor and criterion
variables were measured concurrently. Future GE longitudinal
studies should also examine the association of PE and NA interac-
tions over time in large samples allowing examination of potential
differences in affective versus nonaffective psychosis diagnoses.
This would shed light on the complex relationship between affect
and psychosis and potential similarities and differences in pheno-
types with a predominance of each component.
Conclusions
Overall, the study provides evidence of individual differences in the
interaction of genetic variation with proximal environmental fac-
tors in nonclinical and incipient psychosis groups. Future studies
should employ ambulatory assessments to investigate potential
mechanisms involved in the interplay of positive momentary expo-
sures with protective individual variation in relevant genes for the
homeostasis of the HPA axis, which may result in an adaptive
response to stress in the realm of daily-life. Moreover, empirical
evidence from research examining patterns of reactivity to the
Figure 2. Group differences between nonclinical and early psychosis groups in the interaction of feeling cared for by others with FKBP5 haplotype on psychotic experiences and
negative affect.
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environment could encourage real-world targeted strategies based
on the knowledge of individual differences in the reactivity from
negative to positive factors in the field of psychosis. This is a critical
issue given that, despite intense efforts in the early intervention
paradigm [50], there continues to be a great amount of therapeutic
helplessness associated with psychosis risk outcomes.
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